No Data
No Data
No Data
No Data
No Data
Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
PDF Version CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target fa
Black Diamond TherapeuticsApr 24 00:00 ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers180 Life Sciences (NASDAQ:ATNF) shares moved upwards by 7.4% to $2.04 during Tuesday's after-market session. The market value of their outstanding shares is at $1.7 million. ABVC BioPharma (NAS
BenzingaApr 23 16:31 ET
Garry Menzel Joins GHO Capital as Operating Partner
Garry Menzel joins GHO Capital as Operating Partner Former CEO of TCR2 Therapeutics with significant investment and operating experience to support deal origination and provide best in class services to pioneering
GlobeNewswireApr 23 07:45 ET
Black Diamond Therapeutics Announces Changes to Board of Directors
PDF Version CAMBRIDGE, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target fa
Black Diamond TherapeuticsApr 11 00:00 ET
Black Diamond Therapeutics (BDTX) Gets a Buy From Piper Sandler
TipRanksApr 9 07:07 ET
Black Diamond Theraptcs Is Maintained at Outperform by Wedbush
Black Diamond Theraptcs Is Maintained at Outperform by Wedbush
Dow JonesApr 8 11:29 ET
No Data
No Data